Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Agnosia 1

Interventions

Nivolumab 2Docetaxel 2tivozanib 1gallium 68 PSMA-11 1atezolizumab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Specimen Handling 1Paclitaxel 1Oxycodone 1Menogaril 1Magnetic Resonance Imaging 1Ketorolac 1Ketamine 1Interleukin-2 1Genome 1Genetic Testing 1Etoposide 1Cisplatin 1Carboplatin 1CYT003-QbG10 1Biopsy 1Acetaminophen 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × Ketorolac × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡